CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
Follow CVS
CVS Health Corporation (CVS) Return on equity
CVS Health Corporation's return on equity over the twelve months to 30 June 2026 was 6.21%, up 3.9 percentage points from fiscal 2025 (2.34%). Over the past ten years it has ranged from −1.23% (fiscal 2018) to 17.8% (fiscal 2017); the current reading is higher than 18% of that period. That is below the Healthcare Plans industry median of 8.99% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 2.34% | (3.72) |
| FY2024 | 6.06% | (5.18) |
| FY2023 | 11.2% | 5.38 |
| FY2022 | 5.86% | (5.17) |
| FY2021 | 11.0% | 0.30 |
| FY2020 | 10.7% | (0.08) |
| FY2019 | 10.8% | 12.04 |
| FY2018 | −1.23% | (19.00) |
| FY2017 | 17.8% | 3.41 |
| FY2016 | 14.4% | 0.43 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 34.2% |
| CI Cigna Group compare | 15.4% |
| ELV Elevance Health, Inc. compare | 11.2% |
| HUM Humana Inc. compare | 6.81% |
| CVS CVS Health Corporation | 6.21% |
| UNH UnitedHealth Group Incorporated compare | 0.00% |
| MOH Molina Healthcare, Inc compare | −0.16% |
| CLOV Clover Health Investments, Corp. compare | −5.10% |
| CNC Centene Corporation compare | −20.4% |
| Healthcare Plans industry median | 8.99% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement